曲龙博士1983年在国内获得骨科硕士学位。1985年留学日本,1989年获医学博士学位。1992年在日本东京大学做博士后研究,任东京大学医学部骨外科客座教授,1997年归国。现任北京航天731医院骨外科主任和北京骨延长、骨搬移治疗中心首席主任医师。中华医学会北京分会骨科专业委员会委员,中华医学会骨科学分会骨科显微修复重建学组委员。曲龙博士长期从事骨延长、骨搬移技术的研究和临床工作,擅长骨科疑难病的诊断和治疗,他技术精湛,富有创新精神,经常受邀参加国内外骨科学术交流,他“不为书云所云”的学风,在国际上享有很高知名度。2009年8月,曲龙博士的专著《骨搬移治疗骨缺损与骨不连―Ilizarov技术的临床应用》由人民卫生出版社出版发行。由他首先发现骨搬移过程中的组织凋亡转化后再生的现象被国际上命名为“哈尔滨现象(Harbinphenomenon)”,并独创“骨内骨搬移技术(Harbinhip)”治疗股骨头坏死及“骨搬移微血管网重建技术(Microvascularnetworkreconstructionduringbonetransport)”治疗血栓闭塞性脉管炎的最新方法。目前应用骨搬移技术已治疗了几百例病人,其中包括骨短缩畸形、骨缺损、骨不连接、慢性骨髓炎、股骨头坏死、血栓闭塞性脉管炎、动脉硬化闭塞症等疑难病例,是我国进行该类手术最多的医生。曲龙博士的行医理念是:我们的每一次手术操作,都是把自己的名字、人品、技能雕刻在病人身上的过程,护佑患者,就是爱护我们自己。Dr.LongQureceivedhisMaster’sDegreeinOrthopedicsdomesticallyin1983.In1985hewenttoJapanforfurtherstudyinorthopedicsandgainedhisDoctor’sDegreein1989.Dr.Quconductedpost-doctoralresearchinTokyoUniversityin1992andwasthevisitingprofessorintheOrthopedicsDepartmentofTokyoUniversityMedicalSection.HereturnedtoChinain1997.Dr.QunowactsastheDirectorofOrthopedicsDepartmentofBeijingAerospace731HospitalandtheChiefPhysicianofBeijingBoneLengthening&BoneTransportTreatmentCenter.HeisamemberofChineseSocietyofOrthopedicswhichisasubdivisionofChineseMedicalAssociation(CMA)BeijingBranchandalsoamemberofMicrosurgeryRepairandRebuildGroupwhichisunderCMAOrthopedicsSociety.Dr.Quhasbeenengagedinresearchandclinicalexperimentsonbonelengtheningandtransport.Heiswellrecognizedfordiagnosingandtreatingbonerelatedcomplications.Heisknowledgeableandproficientinhisfield.Innovativeandwillingtoadoptnewtechnologies,heoftenattendsdomesticandinternationalexchangeseminarsandiswellknownforhis“notonlyrelyingonwhatbooksays”practicalstyle.InAugust2009,Dr.Qu’s“BoneTransportTreatmentforBoneDefectsandNon-Union-ClinicalApplicationofIlizarovTechnology”waspublishedbyPeople'sMedicalPublishingHouse.Dr.Quwasthefirstinhisfieldtodiscoverthe“HarbinPhenomenon”.“HarbinPhenomenon”istheregrowthoftissueafterprogramcytoapoptosifitsduringbonetransporttreatment.HealsoinventedtheIntraosseousbonetransporttechniqueforthetreatmentofnecrosisoffemoralhead(HarbinHiptechnique)andmicrovascularnetworkreconstructionduringbonetransporttotreatThromboangiitisobliterans(TAO).Hundredsofpatientswhohadbonecomplicationshavebeencuredwithbonetransporttechnology,includingshortboneabnormality,bonedefects,bonenon-union,ChronicalOsteomyelitis,Necrosisofthefemoralhead,Thromboangiitisobliterans(TAO)andArterialosclerosisobliterans(ASO).InChina,Dr.Quisthemostexperienceddoctorinoperationsusingbonetransporttechnology.Dr.Qubelievesthatweembodyournameandreputationineveryoperationconducted,thereforeweshouldtakecareofourpatientsastakingcareofourselves.
查看简介